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Ii has become apparent it, the la, few years that vascular 
eado:hcli,!m ccntmls ad coordina:cs :be :ooe of blood 
vessels throughout the vascular tree b) producingapowerful 
vasodiitor ,hat may bc the endogenous prototype of the 
nitrovasodilator drugs. It is a finding with far-reaching em- 
plications for our understanding of vascular pathophysiol- 
ogy. 
The clue came firm elucidation of the paradox. iong 
known to pha;mxolo~$sts. that acetylchobne generally coo- 
siricts arteries when these are studied as is&ted strips ii, the 
organ bath, whereas it generally dilates them in VIYJ. In 
1980, Furchgott and Zawadski (I, reported that a dilator 
response to acetylthoiine could be obtained in tsolated 
anerial strip if their enoothelium WE carefully preserved 
during preparation. The endothelium depentlen, dilat!Ji re- 
sponse could apparently wa’ide ,he direc, constrictor 
a&n of aceiyicholinc on Ihr vascular smooth mu%ic. 
Pharmaculogic experiments demonstntiag tha, thi? re- 
sponse could no, be due to prort+zyclin led to the reco$,ni- 
lion tha, sndothelium ~ctea~es a second and arguably more 
important vasodilatar agent that has become known as 
endothelium-derived relaxing factor 12). 
What Is Endothelium-Derived 
Relaxing Factor? 
The nature of endothelium-derived relaxing faclor has 
bren ehplorod by Sioassay experiments. in which the eMuen, 
cram an endotheliel source lsush as an imact artw or 
cuitered endothelinl cell preparation) was found to dilate 
precon\tric,cd anerial prepara:ions ,ha, had been denuded 
ofcndolhelium (3). These experiments confirmed lhc initial 
sugestian on the hasis of sandwich experiments hat cndo- 
theiium-dcrivcd relaxing factor could be a diffusible agent 
(I). and it hecame apparent that this factor, derived either 
from intact arteries or from cultured endothclial cells, was a 
novel substance with a half-life of only seconds in oxygen- 
ated aqueous buffer (3.4). I1 war inactivated by a vxiely of 
ar.tioxidanrs (3), but its short half-life could be prolonged by 
superoxide dismutae, indicating that it was being destroyed 
also by oxidation with the stqxroxide radical (5.6). 
Is it nitric oxide: The idea that endothelium-derived 
relaxing factor might be nitric oxide emerged from consid- 
eration of analc~ous findings witt the nitrowodilators (7). 
with acid activation of inorganic nitrite, which generates 
nitric oxide. and with aa~eous olutions of nitric oxide zas 
(8,9). Nitric oxtdc can indeed be identified in effluent &I- 
tainine “endothelium-derived relaxinz factor activity” (101. 
as it can be gcncraicd by acid activation of extracts fmm 
arterial and other tissues where inorganic nitrite has been 
shown to be its source (I I k but differential responsiveness to 
the relaxing faclor and to sulutions of nitric oxide among 
diiTcrcot smooth muscle preparations (12) ieaves man for 
doubt about whether it is actually nitric oxide itself or a 
source of it. Indeed endothelium-derived relaxing factor 
could be bound nitric oxide. There is some evidence for the 
existence of such o binding agent in biologic extracts (I I). 
Nitric oxide is a simple but reactive gas. How it is produced 
and controlled for biologic use remains to be elucidated 
although it sterns likely that its precursor is the amino acid 
@nine (IZa). The production ofendotheliumderived relax- 
ing factor is known to require sdcnosine triphosphate (ATW 
syn&esis. pmbably by mitochondria, and the avaiiability of 
extracellular calcium (2.13.14). 
Is there mwe than one relaxing faclor? It has been sug- 
gested that there may be mire than one endothelium-derived 
rc!zxing factor, hut many workers in the field remain to be 
convinced. What is hecpming clear is that endothelium is 
rcsponsiblc also for releasingtwoother agcnta-onc, known 
as endoihelium-derived contracting factor, cawes constric- 
tion, and the other, known as endothelium-derived hyperpo- 
larizing factor, causes hypcrpolarization of vascular smooth 
muscle. To remove any vestige of ambiguity. the endothe- 
liun.derived relaxing factor discussed in this review is 
considered to be the agent responsible for thu pheromenon 
Hurst described by Surchgott and Zawad-ki (I) and still 
known by many as “the Furchgott factor.” 
Endothelium-Derived Relaxing 
Factor Release 
Endothelium-derived relaxing factor is produced contin- 
ttously in the basal unstimulated state (3) and its production 
can be sttmulated by a number of agents (Table I). There are I LcaO ww”y I 
major differences among different arteries both in the basal 
level of endothelium-dorived relaxing factor activity (that is, 
its release or response to it, or both) and in the agents that 
can stimulate its activity (15.16). 
Basal mdoorkelium-derived r&ring ~“actor ocriviry ib so 
great in isolated preparations of coronary arteries, for exam- 
ple, that it virtually prevents any constrictor response to 
standard pharmacologic constrictor agonists (IS) (Fig. I). In 
other typ& of arteri& basal endoth&tmderived relaxing 
factor activity can be completely overriden by constrictor 
agonists. Crossover bioassay experiments have now shown 
that these ditTerences in basal activity are due both to 
di!TerenFes in the amotmt of endotlielium-derived relaxing 
factor released (unpublished observations) and to differences 
in the recwnse of the vascular smc,atb muscle to the factor 
Figure 1. Cancenuadon.mpans curves to histamine W&es~. 
acetylcholine @quups), j-hydmxytryptamine (dreks~ and phenyl- 
ephrine (diPnwnd.$ in rabbit coronary artery preparations denuded 
uf endothelium (left WeI) and with endothelium preserved (right 
panel). Note that experimentally-induced local endathelii dqmage 
converts the local constrictor response to any agonist from that 
represented in the right panel to that nprcscnti in the left panel, 
that is. nonspecific r krsiblc “spasm.” 
Ptg~~e Z. Diagram ilkwaling mecban~sms underlymp d0P”“Tl”e 
contraction i V~IEIJI~I smooth mw;!e 0eft panel) anll 
mechanism* oi cyeiic guano& monophmphate GMPI 
(mktdls peed) and cyclic edcnorinc monophosphate 
(AMP) Wgbt pmet) mediated relaxation. A = constnc. 
++ “I “:::~L 
tar agoilist; ad. eyctase = adenylo,e cyclasc; CP = - 
contractile proteins: DAG = diacylglycerol: ER = en- 
---Y-- T”i. I.CYcIaIC 
& 
,a* c”c,aIc 
doplasmic reticulum: Hb = hemoglobin: IP, = inosltol z----. 
tri~l!o~~ha,e: I -M!_CK = phosphorytatcd myurm light 
chain kinase: RKA = protein kinase A; PrKC = protein 
kinase C; PrKO = protein kinase C; ROC = receptor- 
operatedchannel; S = stimulantofendothrlsm-derived 
relaxine factor (EDRFI eroductmn from endothekem: 
sol. g.&clase = solubl; gui~ylle ~ycla~e: VOC = 
voltage-operated channel. 
(17). Among the many aRents that sumulate cndotbclium- 
derived rcl&ing fa&r activity is the calcium ionophore 
A23187. This comoound imolicates calcium in the meclw . 
nism of relaxing factor release and incidentally pmvides a 
useful experimental means of bypassin& receptor mccha- 
nisms. 
Endorhelium-derived relaxing factor release is oho pow 
dependent (&ZOJ, a phenomenon that may perhaps be 
mediated by calcium channels in the endothclial membrane 
Ihat are influenced by shear stress (22). 
Action of End&helium-Derived 
Relaxing Factor 
Slimuldion d srdubk gusnylde cycle. Several steps in 
the action of endothclium-derived relaxing factor have now 
been clarified. :f it is simpiy nitric oxide, it will readily 
penctratc the cell membrane and bind to the ferrous-heme 
moiety of soluble guanylare cyclase. which is thus activated 
to raise the level of cyc!ic guanosine monophosphate (GMP) 
within the cell (2%24). This raised level in turn activates the 
cyclic GMP-dependent protein kinase (2% which then phos- 
phorylates as yet largely unknown proteins to alter their 
function. Endotbclium-derived relaxing factor may be rc- 
gxded as the endogenous analogue of the nitmvasodilator 
drugs, whose mode of action is thought to bc generation of 
nitric oxidzdirectly. in the case of sodium oitroprusside or 
molridomine. and indirectly, by way of inorganic nitrite, in 
khe case of the other organic nitrates. Note that the atrial 
nattiuretic peptides, which also elevate cellular cyclic CiMP 
levels, achieve this action by different meats: they act by 
way of their receptors to stimulate portiadale guanylate 
cyclase (261, an enzyme that is mechanistically and hence 
phamtacologicaliy quite distinct. 
Elfat cd cyclic guanosine mocophospbate M vawtlar 
smooth muscle contraction. Contraction of vascular smooth 
muscle is due to activation of the contractile proteins by a 
rise in the level of free cytosolic calcium (27) accompanied 
by activation of the calcium- and lipid-dependent protem 
kinase C (28). The increase in cytosolic calcium is brought 
about both by mobilization of calcium from endoplasmic 
randurn *wthin the cell and by entry of calcium from the 
extracellular space (Fig. 2). Constrictor agocists, through 
occupation of their specific receptors. cause hydrolysis of 
membrane phosphoinositides into inositol 1.4.1 triphosphate 
(InsP,). urbicb mobilizes calcium through channels in the 
endoplasmic reticulum 129). Phosphoinositide breakdown 
also produces diacylglycerol. which activates cytoplasmic 
protein kinasc C (28) and leads to phosphorylation of con- 
trolling proteins, as yet undefined; one consequence appears 
to he to iocreaze the sensitivity of the contractile proteins to 
calcium (30) In addition, constrictor agonists open calcium 
channels in the cell membrane by mechanisms not yet clear. 
There is one study (31) that shows that receptor occupation 
can be directly linked to opening of “receptor operated” 
channels. whereas in two other studies, either fnsP, (32) or 
inositol I .3,4.5 tetnphoaphate (InsP,) (33) may function es 
soluble second messengers that open calcium channels from 
the cytoplasmic face of the cell membrane. Thrre may also 
be calcium entry through coupled vol:agc-gated channels 
(34). 
Mewion upcyclic GMP, whether induced by nitroprus 
side or cndotheliumdcrived relaxing fac:or. causes inhibi- 
tion both of calcium release from internal stores and of 
calcium influx through “receptor-operated” channels (35). 
This inhibitioa, by implication. is responsible for a reduction 
in the agonist-stimulated l vels of free calcium that has been 
demonstrated by direct measurement in the case of nitro- 
prusstde (27). Cyclic GMP is known to inhtbit stimulated 
phosphoinosotide tumover (36). This ability could account 
for its inhibition of calcium mobilization and also for its 
inhibition of calcium influx if this is triggered by InsP, or 
InsP,. A direct action on “receptor-operated” channels is 
not. however, excluded. 
Dierences between cycl* gttatwitw nmnophosphate snd 
cyclic adenesinc manopbc8pbatemediated relax&n. Eleva- 
tion of cyclic AM&as induced, for example, by adenosine, 
prostacyclin or beta-adrenergjc stimulation-appears to act 
not by reducing levels of cytosolic free calcium but by vein (41). where bioassay experiments confirm that it is 
stimulating phosphorylaiion of myosin light chain kinase and produced by the wwus endothelium (unpublished observa- 
thus dccrcasing the calcium sensilivity of the contractile tmns). There is no evidence about endothelium-derived 
proteins (371. These agents therefore have the ability to act rclaning factor activity in vein9 in viva. 
additively or even synergistically with endothelium-derived 
relaxing factor, as has &en shown in the context of platelet 
aclivation. 
Action OF Endothelium-Derived Relaxing 
Factor in Resistance Vessels 
Hemoglobin Inhibits Endothelhun-Derived 
Relaxing Factor Activity 
Nitric oxide is bound also by the ferrous-heme moiety of 
certain heme-containing proteins that compete for it with 
solubie gwylate cyclase (38). Hemoglobin or myoglobin 
inhibits the action of endothelium-derived relaxing factor, 
whereas mcthemoglobin is much less potent (38). Hemoglo- 
bin has proved a useful pharmacologic tool because it 
inhibihs the action of endothelium-derived relaxing factor 
and nitrovasodilatoro but not that of agents that act by way 
of particulate guanylate cyclasc. 
PIammo has also been shown to inhibit endofhelium- 
derived relaxing facror action. This effect is due to hemo- 
globin bound to baptoglobir. as tbc baptoglobin-hemoglobin 
complex at concentrations normally found in human plasma 
(39). Quantitatively more important in whole hlwd may be 
the large pool of hemoglobin within the red cells that nitric 
oxide would readily penetrate. This pool of intravascular 
hemoglobin does not apparently inhibit endotbelium-derived 
relaxing factor-induced vasodilation in viva (40). In aqueous 
buffer, it presumably penetrates the functionally impaired 
endothclial barrier to interact with the relaxing factor in 
transit between endothelium acd subjacent vascular smooth 
muscle, whereas in viva .where the endothelial barrier is 
intact. this penetration may not M‘CUT. 
Resistance vessels are more dimcult to study lhan ale the 
larger conduit arteries in which most of the experimental 
work on endothelium-derived re!axiag factor has been cer- 
ried out. However. there is consistent evidence from iso- 
lated vascuk.r preparations (42-51) and perfused hearts (52) 
that relaxing factor activity is present in microvessels. 
Indeed the studies in isolated vascular beds (see next para- 
graph) suggest hat endolhelium-derived relaxing factor may 
be particularly important in resistance vessels. 
Endothelium-derived relaxing f*r actit tn an intact 
wculsr bed. Vasomotcn restxmses at any Cen point in an 
intact network will, of co&, depend oa local r&ponsive- 
new The reswnse will also be influencei: $9~ Ihe level of 
ambient tone &presenting the starting point of any constric- 
tar or dilator response toward the ceili% or floor of that 
vessel’s potential vasomotor range (5L). Vascular tone will 
also be passively influenced by the conseqwnces of changes 
occurri& in distant (proximal or disral) vessels-for exam- 
ple, “upstream” vasoconstriction will tend to reduce 
“downstream” intraluminal pressure, thereby secondarily 
affecting downstream va.swlar caliber. Furthermore, enda- 
lbelium-derived relaxing faclor will mediate dilation in re- 
sponse to iuxw.cd i3ow and thus actively influence vast- 
motor tone in response to chenges in Row that are mediated 
by changes in constrictor tone induced in distant vessels- 
indeed the action of the relaxing factor may coordinate 
vasomotor behavior throughout the system despite i!s PO_ 
Localized Action of Endothelium-Derived tential complexity. An understanding of va.scular behavior 
Relaxing Factor 
under physiologically relevant conditions nwl rherefore be 
based on studies in the intact vascular bed. 
It has been shown experimentally that endothelium- Implicetirms ef Aowdepeudent release d eadothelium- 
derived relaxing factor ects only very locslly on immediately derived relaxing f&or, studied in &stance ~w-ssets. Experi- 
subjacent vascular smooth muscle, with negligible intravas- mcnts with the pc!fttsed rabbit car. with use of microangio- 
CUIK action downstream (40). These actions may he albib- graphy lo measure.vessel diameter down to approximately 
uted primarily to the instability of the relaxing factor, which 7O#m, have yieldsi sowe interesting find&s &out the way 
is likely to be dce at least in pan to !he presence of in which an ialact vascular bed nsponds to sudden changes 
superoxide radicals. The presence of hemoglobin in red cells in flow and the role ofcndothelium-derived relaxing factor in 
end bound to haptoglobin in plasma provides e iurther these responses (47). Hemoglobin was used to inhibit basal 
mechanism to localize the relaxing factor activity. Row-related relaxing factor activity in this buffer-perfused 
preparation, and thereby reveal its influence. 
Action of Endotbelium-Derived R&xing These experiments coafimtd (her bawl endorhelium- 
Factor in Veins 
derived re!erin~ factor acriviry is presear in resis!we 
vessels in situ; hs aclivity was highest in the generation of 
VeinsgeneraW exhibit little orn~ relaxingfectoractivity, vessels (approximately 150 +n diameter) in which hydraulic 
though it can be demonstrated in portal or pulmonary vein resistance and shear stress were also highest. These vessels 
preparations and has been reported in the human saphenws arc topographically “feed vessels” in that they divide with- 
out anastomosing. Endothelium-dewed relaxing factor was this way. it may be said to coordinate the distribution of 
thus most active at the sites of greatest “mechanical lever- Row-m a sense. to prevent vasctdar “EleBI.” 
age” for regulating the distribution of Row. 
Expaimcnts with this model ais” con&med in the inwci 
vascular bed that increasing pressure can lead to a secondary 
increase in pressure. attributable toe “myogenic rerpanre.” 
but this increase occurred only in the absence of endothe- 
lium.derived relaxing factor activity and was abolished when 
this activity was present. IntereSiogJy, there is evideocc that 
this myogenic response itself involves the participation of 
endathelial cells (a reversible, non-cytotoxic intubitor of 
endothelium-derived relaxing factor activity such as hemo- 
globin is thus required to dissociate relaxing factor acthity 
from other endotkekal intluences). It has long been recog- 
nized that the constrictor rerponse to increased intnhxmnal 
pressure represents a positive feedback mechanism that, if 
unopposed, could lead to instability in the intact circulation 
(53,541. Plowdependent eadothelium-derived relaxing fec- 
tot-mediated dilation provides en opposing positive feed- 
back mechatrism capable of stabilizing the system 
lebibition of Platelet ~~tivatto~ by
E~doth~tium-Derive R laxing Factor 
and Nitrov~tt~to~ 
Plntclrt nctivaiitm. Platekt “actidation” emtmces edbe- 
Analysis of this netwrk’s response to sudden chan,yes in 
J?ow showed that &IV was related to the fourth power of 
vessel diameter, but only when endothelium-derived reiaring 
focror activity was present. When its activity was inhibited, 
the data could,no longer be fitted to an expreesrion of the 
general form: Q = aD’+b, where 0 = Row, D = diameter 
and a and b are constants. In Poi+xtille flow, the presrure 
gradient (dP/dl) is propottional to Q/D4, so that by substitu- 
tion from Q = aD%b, dP/dl becomes proportional to &‘(I -b/ 
Q and will therefore asymptotically approach a constant 
value at high flow rates. This fourth power law thus implies 
that the pressure gradient will become progressively mde- 
pendent of flow rate, a general wnclusion that has been 
experimentelly supported in experiments with conduit arter- 
iCs (55). Increased flow, as for example during exercise. can 
itt this way be accommodated without the huge increases in 
blood pressure that would othetwise be required in the 
absence of Bow-dependent dilatioa. Another implication of 
the fourth power law is that the energy needed to deliver a 
given volume of bleed becomes independent of flow rate et 
high flow; in a rigid tube it would be directly proportional to 
flow. Because this fourth power law holds only in the 
presence of eodothelium-derived relaxing factor activity. 
this factor appears to provide a mechanism that limits the 
work ot pafusion. Esdotheliuot.detived relaxing factor may 
therefore be said to improve the efficiency of the cardiovas- 
cular lyEtent. 
SiOn, Shape ChaOgC, smgegation aod ihC iClCS,e Of 2twi;lC 
product, (zdenosine triohowhate IATPl. adenosine diDhor- 
ihate [ADPI. 5-hydrox~trypkunin~ [S-&l and pmteinisuch 
as platelct-derived growth factor). It is stimulated by. for 
example. ADP. thrombin. platelet-activ-tingfactor, collagen 
and shear stress. hs in vascular smcmtk muscle, this a&a- 
tion involves an rgomst-activated increase in cytorolic cal- 
cium both through mobilizarion of intracellular c&ion a! 
through “receptor-operated“ channels in the plasma mem- 
brane and with activation of the protein kinve C pathway 
(56). Samulus-response coupling mechanisms are, in fact. 
remarkably analogous to those ofsmooth muscle contraction 
(Fig. 2). 
Endothelium-derived relaxise factor and sodium nitro- 
prosside (but not the organic &tes) activate soluble gua. 
nylate cyclase m platelets as in vascular *mooth ems& 10 
elevate &telet le;ela of cyclic GMP (57-59). ‘The increase of 
cyclic GMP concentration activates the cyclic GMP- 
dependent protein kinase end this activation is associated. as 
in smooth muscle, with a decrease of ieternally released 
calcium, of calcium intlox and, hence. of free cyrosolic 
calcium (60) 
Platelet ag#‘ega~. Admintstntion of pharmacologic 
doses of wrbaehol intmvenou~ly to rabbits causes a reduc- 
tion of platelet aggtegability (59). This reduced amegability 
is associated with rased levels of platelet cyclic GMP and 
can be inhibited by hemoglobin infusion, confirming involve- 
ment of endotkclium-derived relaxing factor. These experi- 
ments demonstrate that the latter can infkxnce nlS%et 
aggregability in viva aswell as in vitro, presumably by acting 
on those platelets that pass in very close proximity to the 
endotheliem 
An independent observation is that the :elative caliber 
and thus relative hydraulic resistance of arteries of dierent 
sizes within a vascular network remain the same at dilTerent 
Row rates in the presence 9 eodothelium-derived relaxing 
factor activity though not in its absence 147). The relaxing 
factorthuseppearsto~eontribute to maintainingconstancy f 
the spatial dishibution of flow independently of i&w rate. In 
Physiologic Role of Eadothelium-Derived 
Relaxing Factor 
From what we new know of cndothelium-detived relax- 
ing fectcr, it seems cer..n to play a number of fundamen- 
ta!ly impmtatt physiol@e roles. The story is !ikely to 
unfold with the explosion of new work currently in progress. 
Its known actions PM 1) to mediate vasodilation. and 2) to 
inhibit ploielet aggregatioo-actions that will be very lo&- 
ized to the immediate vicinity of the eodothelial cells releas- 
iqg endothslium-detived relaxing factor. 
“asettlpr nuwib rnwle: reedbatien efvnsndikxtiei~. Ta’Jle 
! lists agents repwtcd te stimulate ettdothelium-derived 
relaxing factor-mediated vasoddatian. We can try to impose 
some order on the types of agents involved and thereby 
determine by tmplicaiion the possible physiologic roles of 
endotheliom.derived relaxing faclor. Stimulant% include cir- 
cub&r! hormones, neurotransmittern and products of plate- 
let a&&n and thrombosis. This list s&csts that &do- 
tbelixo-derived relaxing factor functions as I) a means of 
mediatingva~odilatian 10agents circulating within the blood- 
stream that might not otherwise cross the endothelial bar- 
rier: 21 a common mediator of vasodilation in response to 
ncurotransmitters delivered on the adventitial surface of 
small arteries where diffusion distances to the endotbeliam 
are short; and 3! a local anti-hemostatic mechanism. 
I~dwrcnl diffuenccs among aneriev in fhrir cndolhelinm- 
derived relaring/arror-lnediorrd responses introduce a rich 
complexity into the mential for control throughout the 
vasc~~lar system. It isobviousthat not all arteries possess the 
same receptors to mediate stimulation of endothelium- 
derived relaxing factor release. Vasoprcssin, for instance, 
causes endothelium-dependent vasodilation in cerebral but 
no1 other ancrtcs (61): this finding suggests that endothe- 
hum-derived relaxing factor may have a role in maintaining 
cerebral perfusion during shock, when vasopressin levels are 
increased. There are, moreover, quantitative di&rcwes both 
in the basal rcteaseofendothe!ium-derived r iaxingfactorand 
in the respanse of vascular smooth muscle to it in diiferenl 
arteties. Although these remain to be fully characterized, a 
possible pattern may he discerned in which these diffcrcnc?s 
are related to the extent to which di5erent arteries are 
dependent for their contraction on calcium influx relative to 
calcium mobilized from intnce!lular &ores. Endothelium- 
derived relaxing factor aclivity appears to be relatively Sigh in 
thosearteries thal arcmoredcpendentforilitircontra~tionon 
calcium bvlux (16). such as conduit coronary or cerebral 
art&s or the microvesSels, tnough this geneA hypothesis 
remains to be rigorously telted. It would suggest hat physi- 
ol~gically the most important mechanism of endathe!ium- 
derived rclaxinr: factor-mediated vasodilztion may be inhibi- 
tion of a&mist-stimulated chlciCm influx. 
The mos! imporronr gcn~ral role of mdcfhclium-derived 
reiu&g foc??r may hc il.7 @wrelared ocriviry. through 
which it coordinttcs changes in vessel calihcrthroughaut the 
vascular bed. Metabolic vaeodilation of small arterioles. for 
insian% Cl! result in increased flow throughout the bed. 
leading to mdothelium-derived relaing factor-mediated i- 
lation also of the larger arteries. The ways in which lhe 
relaxing factor rwdinhtes and stabilizes the system and 
optlmizcs cardiwaacular eficicncy were considered earlier 
in this review in rr’ation !o its influence in an intact miwo- 
vascular network. 
In conlrox, ,o rhe fowrh poru Iw, n’hich ~ppean to 
gown wucnlnr responser 10 sudden changes in~7ow. a third 
paver law appears to govern the basic anatomic relation of 
caliber to Row and long-:enn adaptation of caliber to im- 
Fiyrc 3. Mechanioms underlying toealizz.don i response tovascu- 
lu dama@. Activation of Platelets inidated by contact with exposed 
collagen releases ADP. 5.hydroxytryp!amine (5.HT) and thrombox. 
ane ITXA,). all of which potcntiate Platelet activation (PL ACTIV) 
and ~aese wscular constdclion (V/C) (which can insware shear 
stress on platelets and potenliate actkation). When rndothelium is 
intact. ADP. 5-HT lie some arteries) and ATP released by platelet 
activation stinwlatc endothetiom-derived r laxing factor (EDRF) 
production with antiaggregalory (ANTI ACZREG) and varodilator 
IV/D) pmpenies. Endotheliun-derived relaing factor and pmsta- 
cyclin production from endothe!ium at the perimeter of the lesion 
may be enhanced by increased ecdothelisl shear farce due to 
adjaccnl vamconst~icdon. FGI, = pmstacyclin: VW = van Wille- 
brand ktor. 
posed changes in ambient flow rate (62). It may be worth 
notink in this context that shear force varies &an inverse 
cube function of diameter and that endothclium-derived 
relaxing factor activity is related to shear force, so that 
regulation of anery caliber during development of the vas 
c~lar sybtcm or durtng long-tan adaptation to altered flow 
rate implic; normalization of shear force and of endathelium- 
dewed relaxing factor activity. The latter might thus also 
provide an essential functional signal for regulating arterial 
caliber. 
Flatrktsz inhibition of pla~ekl aggrcgatim~. In vascular 
damage with loss of endothelium. platelets will aggregate on 
exposed collagen and bc activatcd~to release ADi. ATP and 
5-HT. stimulating further aggregation and constriction of 
vascular smooth muscle. At the perimeter of the endothelial 
loss. these same agents will stimulate endothelium-derived 
relaxing factor release, resulting in local inhibition of platelet 
aggregation and in vasodilalion (63,641. Endotbelium- 
derived relaxing factor will thus act to locdlizc the rc~poose 
to the damaged area (Fig. 3). 
Endothelium-Derived Hyperpola%ing Factor 
and Endothelium-Derived Contracting Factor 
ko review on endolhelium.derived relaxing faclor would 
be complete without consideration of other factors released 
from endothelium that may contribute to changes in Ihe 
underlying vascular smooth muscle tone. Two factors 
known to influence blood vessel tone are endothelium- 
derived hyperpolariring Sxtor and endothelium-dewed 
constricting factor. 
Acetytchaline-induced. endotbclium-dcpendcnt hyperpo- 
larization of vascular smooth muscle preparations has been 
observed by several workers (65-67). Unlike endotheliwn- 
derived relaxing factor, which induces a prolonged relax- 
ation of vascular smooth muscle, endothelium-derived hy- 
perpolarizing factor induces only tranrient changes m 
membrane potential. Both these factors are non-prostanotd 
in nature, but evidence that Ihe9 are different agcms was 
recently provided (6%). The experiment showed that acetyl- 
choline stimulates the release of endothelium-derived hyper- 
polarizing factor through M, muscarinic receptors. whereas 
it stimulates the release of endothelium-derived relaxing 
factor through MI muscarinic receptors (67al. The chemxal 
nature of the hyperpolariring factor /\ as yet unknown. 
The release ofendotheliumderived contracting factor has 
been shown by a number of groups (6~75). 11 can be 
released from endothelium in response to pressure changes. 
rapid stretching, ekctrical stimulntian and anoxia. and there 
appears also he be a basal release from cultured endothe- 
bum. It has been recentlv identified as a 2t-reddue ocotidr 
(7%) although there is &me evidence for the pruduf!i;~n oi 
both peptide& (69.70) and prostanoid (34.751 wsoconstnc- 
ton by endothelium. 
Pathc~hysiology of Endothelium-Derived 
Relaxing Factor 
Any mechanism as fundamental and widespread as endo- 
thelium-derived relaxing factor must have the potential 10 
contribute to pathophysioiogic conditions, although it is 
premature to consider such contributions as more than 
speculative. Neverthelers we have a number of plittter~. In 
addition to the obvious consequences of gross endothelial 
damage, the wide natural variarioas in endothelium.derivcd 
dewed relaxmg factor actiwty. due in part to the lipid 
- 
barnrr mterposed between endothclmm and vawlar 
_ 
rmooth muccle 177) but also 10 a reductton of endothelium- 
derived relaxmg facror release (78). Reduced rclilning factor 
muscle by disease so that it can no longer contract. 
aclw!ty may hkcwisc underlie the patentmtion of vasocon- 
stnctor rerpunser observed reversibly with diet-mduced 
Cerebral uasoeonstrietiin. The cerebral vasocnnctriction 
atherosclerosis of pnmmes. There iq also widcncc sugert- 
ing :I speofic inhibiting effect of low density lipoproteins on 
that complicates subarachnoid hemorrhage could also be due 
endnthelium-derived relaxing fastor production (791. 
to inhibition of endothelium-derived relaxing factor activity. 
Atheromalous coronary aneriea isolated from homan 
hearts show conwicror response- to acetylcholine. MO?? 
convmcingly. acctylchotinc infusion into human coronary 
m this case by hemoglobin acting as a chemical trap Soi this 
artcries in viva has now been shown to cause dilation in 
normal vessels but constriction in atheromatous vessel<, 
factor m the cerebrospinal fluid that bather the cerebral 
panicuiarly at the site of IeFions 180). More extreme con- 
striction could lead to a vicious cycle of events whereby 
ancrics (381. 
shear-potentiated activa!ion of platelets passing through the 
conw~tvm would release ATP. ADP and S-HT. which 
would further constrict ancrier without local endothetium- 
derived relaxmg factor proteciion white dilating those in 
which relaxing factor activity was intact (Fig. 3). Ergome- 
hine stimulates endothelium-derived relaxing factor release 
in experimental animals (811. so that the resultant of as 
indtrcct dilator and direct constrictor actions depends on 
endurhelial integrity. which could explain why this poten- 
tlally powerful co”stricror agent IS useful as a provocative 
agent m patients susceptible to coronary va?ospasm. Cmh- 
ctcr-induced spasm may be an example of local loss of 
endothelmm-derived relaxing factor activity by endothelial 
damage. ‘That spasm is not seen more often aiter angioplasty 
may he due to concurrent dilator therapy or to associated 
damaec to Ihe arterial media or wlintinz of the vascular 
relaxing factor receptor-mediated stimulation, basal produc- 
tion and action, offer rich scope for xadulation of relaxing 
factor activity in disease, and them is growing e qxrimemal 
evidence that this activity can become impaired in a number 
of conditions. 
Coronary wospasm. Local impairment of endothelium- 
derived relaxing factor activity may well play a part in the 
pathogenesis of clinical oronary vasospasm, although this is 
diliicult to prove. Local damage to endothelium in isolated 
coronary artery preparations locally augments all constrictor 
Hyprteorks~, aging, cardtomyopatby. In enperimenlal 
models of hypertension (82.83) and of diabetes C&V, there is 
loss of cndothelium-dependent relaxation, probably as a 
secondary phenomenon. Aging itself impairs endothcdum- 
dependent vasodilalion hut not the smooth muscle response 
to nitrovasodilarors, suggesting a relatively specific decline 
of endotheliumderived relaxing factor activity with age (83). 
Whe!bL, impairment of such activity in microvessels con- 
tributes to the microvascular spasm postulated to underlie 
some experimental and clinical cardiomyopathies (85) re- 
responses (Fig. I) (IS). When acetylcholine was used as a mains a matter of speculation. 
lest drw, local damage to canine coronary arteries in viva Athernaenesb. The ~elatton between endothelium.de- 
changed‘ the normal dilator retponse to i constrictor re- rived relaxing factor production and atherogenesis ib so far 
span% (76). In experimental mod& of atherosclerosis (as in onexplored. Nitrovasodilators are known to influence mass 
the lipid-fed rabbit) there is impairment of endothelium- transport through the wall of large arteries 186). It is theo- 
ti& lhai occurs among the several cell types in nomml and 
diseased aneries. Studying the ueture and function of those 
messa&es is likely to preoccupy vascular biologists for Mary 
years to come. Certainly. the rapid progress in undexhnd- 
ing the production and action of endalhelium-derive1 relax- 
ingfactor has already added a new dimension to our thinking 
on vawmotor control. The elucidalion of its role in vascular 
pathology promises to be at leasl as exciting. 
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